Health Catalyst reported a 1% increase in total revenue, reaching $74.7 million for the first quarter of 2024. The company's Adjusted EBITDA was $3.4 million. They are reiterating the full year 2024 total revenue and Adjusted EBITDA guidance ranges and also reiterating both of their bookings metrics, inclusive of dollar-based retention rate and net new DOS Subscription client additions.
Total revenue for Q1 2024 was $74.7 million, a 1% increase year-over-year.
Adjusted EBITDA for Q1 2024 was $3.4 million.
The company is reiterating its full-year 2024 revenue guidance of $304.0 million to $312.0 million.
The company is reiterating its full-year 2024 Adjusted EBITDA guidance of $24.0 million to $26.0 million.
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA. For the second quarter of 2024, the company expects total revenue between $73.5 million and $76.5 million, and Adjusted EBITDA between $5.0 million and $7.0 million. For the full year 2024, the company expects total revenue between $304.0 million and $312.0 million, and Adjusted EBITDA between $24.0 million and $26.0 million.
Visualization of income flow from segment revenue to net income